Next Article in Journal
Injectable Polypeptide Hydrogel Depots Containing Dual Immune Checkpoint Inhibitors and Doxorubicin for Improved Tumor Immunotherapy and Post-Surgical Tumor Treatment
Next Article in Special Issue
Therapeutic Performance Evaluation of 213Bi-Labelled Aminopeptidase N (APN/CD13)-Affine NGR-Motif ([213Bi]Bi-DOTAGA-cKNGRE) in Experimental Tumour Model: A Treasured Tailor for Oncology
Previous Article in Journal
CD13-Mediated Pegylated Carboxymethyl Chitosan-Capped Mesoporous Silica Nanoparticles for Enhancing the Therapeutic Efficacy of Hepatocellular Carcinoma
Previous Article in Special Issue
Cancer-Associated Membrane Protein as Targeted Therapy for Bladder Cancer
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(2), 427; https://doi.org/10.3390/pharmaceutics15020427
Action Date Notes Link
article xml file uploaded 28 January 2023 07:18 CET Original file -
article xml uploaded. 28 January 2023 07:18 CET Update https://www.mdpi.com/1999-4923/15/2/427/xml
article pdf uploaded. 28 January 2023 07:18 CET Version of Record https://www.mdpi.com/1999-4923/15/2/427/pdf
article supplementary file uploaded. 28 January 2023 07:18 CET - https://www.mdpi.com/1999-4923/15/2/427#supplementary
article html file updated 28 January 2023 07:19 CET Original file -
article html file updated 1 March 2023 11:22 CET Update -
article html file updated 8 March 2023 02:54 CET Update https://www.mdpi.com/1999-4923/15/2/427/html
Back to TopTop